Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

LITTLE RIVER HEALTHCARE CENTRAL TEXAS LLC

NPI: 1619303641 · CAMERON, TX 76520 · Family Medicine Physician · NPI assigned 09/23/2013

$1K
Total Medicaid Paid
496
Total Claims
494
Beneficiaries
6
Codes Billed
2018-01
First Month
2018-03
Last Month

Provider Details

Authorized OfficialMADISON, JEFFREY (CEO)
NPI Enumeration Date09/23/2013

Related Entities

Other providers sharing the same authorized official: MADISON, JEFFREY

ProviderCityStateTotal Paid
ROCKDALE BLACKHAWK LLC ROCKDALE TX $5K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 496 $1K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 188 188 $704.64
84311 40 40 $176.00
82570 40 40 $130.50
83986 40 40 $90.00
81003 40 40 $56.50
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 148 146 $0.00